Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer

Advanced pancreatic cancer (PC) is an aggressive malignancy with few effective therapeutic options. While the evolution of precision medicine in recent decades has changed the treatment landscape in many cancers, at present no targeted therapies are used in the routine management of PC. Only a minor...

Descripción completa

Detalles Bibliográficos
Autores principales: Berry, William, Lundy, Joanne, Croagh, Daniel, Jenkins, Brendan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836067/
https://www.ncbi.nlm.nih.gov/pubmed/29382047
http://dx.doi.org/10.3390/cancers10020035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836067/
https://www.ncbi.nlm.nih.gov/pubmed/29382047
http://dx.doi.org/10.3390/cancers10020035

Ejemplares similares